Hint mode is switched on Switch off
For swift navigation between sections

Domestic bonds: Ligand, 0.75% 15may2023, USD (Conv.)
US53220KAF57

  • Placement amount
    750,000,000 USD
  • Outstanding amount
    147,527,000 USD
  • USD equivalent
    147,527,000 USD
  • Denomination
    1,000 USD
  • ISIN
    US53220KAF57
  • CFI
    DCFNGR
  • FIGI
    BBG00KXRV5J3
  • SEDOL
    BJVRG82
  • Ticker
    LGND 0.75 05/15/23

Find Any Data on Any Bond in Just One Click

Full data on over 500,000 bonds and stocks worldwide

Powerful bond screener

Ratings from the top 3 global ratings agencies, plus over 70 local ones

Over 300 pricing sources from the OTC market and world stock exchanges

User-friendly and intuitive across multiple platforms

Get access

Trading chart

Stock exchange selection
Stock exchange selection
More about Cbonds Estimation
Data display in a chart | table
Data display in a chart | table
Work with the chart: switching the price, period, issue comparison
Work with the chart: switching the price, period, issue comparison
Download the chart in a convenient format
Customize fields in the table
Found:
Show all fields
* Data is not available within the selected subscription
Quotes from market participants are indicative

Stock exchange and OTC quotes

Issue information

Profile
Ligand Pharmaceuticals Incorporated (Ligand) is a biotechnology company that operates with a business model focused on developing or acquiring assets. The Company’s technology portfolio CAPTISOL is a formulation technology that has enabled five Food and Drug ...
Ligand Pharmaceuticals Incorporated (Ligand) is a biotechnology company that operates with a business model focused on developing or acquiring assets. The Company’s technology portfolio CAPTISOL is a formulation technology that has enabled five Food and Drug Administration (FDA) approved products, including Pfizer’s VFEND IV and Baxter International’s Nexterone and is being used in a number of clinical-stage partner programs. The therapies in its portfolio in development address the unmet medical needs of patients for a spectrum of diseases, including hepatitis, muscle wasting, Alzheimer’s disease, dyslipidemia, diabetes, anemia, asthma, rheumatoid arthritis and osteoporosis. It’s wholly owned subsidiaries include Ligand JVR, Allergan Ligand Retinoid Therapeutics, Seragen, Inc., Pharmacopeia, LLC, Neurogen Corporation, CyDex Pharmaceuticals, Inc. and Metabasis Therapeutics. 
  • Issuer
    Go to the issuer page
    Ligand
  • Full borrower / issuer name
    Ligand
  • Sector
    Corporate
  • Industry
    Pharmaceutical Preparation and Biotechnology
  • Stocks
Volume
  • Placement amount
    750,000,000 USD
  • Outstanding amount
    147,527,000 USD
  • Outstanding face value amount
    147,527,000 USD
Nominal
  • Nominal
    1,000 USD
  • Outstanding face value
    *** USD
  • Integral multiple
    *** USD

Cash flow parameters

  • Reference rate
    ***
  • Coupon Rate
    ***
  • Day count fraction
    ***
  • Interest Accrual Date
    ***
  • Coupon frequency
    *** time(s) per year
  • Payment currency
    ***
  • Maturity date
    ***

Early redemption terms

***

Find Any Data on Any Bond in Just One Click

Full data on over 500,000 bonds and stocks worldwide

Powerful bond screener

Ratings from the top 3 global ratings agencies, plus over 70 local ones

Over 300 pricing sources from the OTC market and world stock exchanges

User-friendly and intuitive across multiple platforms

Get access

Placement

  • Placement method
    Open subscription
  • Placement type
    Public
  • Placement
    ***
  • Geographic breakdown
    ***
  • Investor breakdown
    ***
Participants
  • Bookrunner
    ***

Conversion and exchange

Additional information

***

Latest issues

Identifiers

  • ISIN
    ***
  • CUSIP
    ***
  • CUSIP 144A
    ***
  • CFI
    DCFNGR
  • FIGI
    BBG00KXRV5J3
  • WKN
    A2R2PG
  • SEDOL
    BJVRG82
  • Ticker
    LGND 0.75 05/15/23
  • Type of security by CBR
    ***

Bond classification

  • Senior Unsecured
  • Registered
  • Coupon bonds
  • Convertible
  • Trace-eligible
  • Amortization
  • Callable
  • CDO
  • Dual currency bonds
  • Variable rate
  • For qualified investors (CIS region)
  • Foreign bonds
  • Green bonds
  • Guaranteed
  • Inflation-linked principal
  • Supranational bond issues
  • Inflation-linked coupon
  • Mortgage bonds
  • Perpetual
  • Payment-in-kind
  • Non-Marketable Securities
  • Redemption Linked
  • Restructuring
  • Retail bonds
  • Covered
  • Securitization
  • Structured product
  • Commercial Bonds
  • Subordinated
  • Sukuk

Restructuring

***

Registration is required to get access.